Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS

NCT02446886 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT02446886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02446886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2016
Completion date
June 30, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis